Table 1.
Assessment schedule
| Evaluation | Screen/enrolment log | Baseline | Day 1 | 72-h monitoring chart | 7 days or hospital separation (discharge, transfer, or death) | 6-month follow-up |
|---|---|---|---|---|---|---|
| Forms | A | B | C | D/E | F | G |
| Screen | X | |||||
| Eligibility | X | |||||
| Consent/re-consent | X | |||||
| Contact details | X | |||||
| Vital signs | X | X | X | X | ||
| Physical parameters | X | |||||
| GCS | X | |||||
| NIHSS | X | X | ||||
| Medical history | X | |||||
| mRS | X | X | ||||
| EQ-5D | X | |||||
| Routine blood tests | X | X | ||||
| Brain imaging | X | X | X | |||
| Standard stroke care | X | X | ||||
| Final diagnosis | X | |||||
| Medications in use | X | X | X | X | ||
| SAEs | X | X | X |
EQ-5D EuroQoL Group 5-Dimension self-report questionnaire, GCS Glasgow Coma Scale, mRS modified Rankin scale, NIHSS National Institutes of Health stroke scale, SAEs serious adverse events